Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
This study is ongoing, but not recruiting participants.
Sponsor:
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
Onyx Pharmaceuticals ( Onyx Therapeutics, Inc. )
ClinicalTrials.gov Identifier:
NCT00511238
First received: August 1, 2007
Last updated: August 8, 2012
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2013 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
No publications provided by Onyx Pharmaceuticals
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):